(Press-News.org) People who are depressed are less likely to adhere to medications for their chronic health problems than patients who are not depressed, putting them at increased risk of poor health, according to a new RAND Corporation study.
Researchers found that depressed patients across a wide array of chronic illnesses such as diabetes and heart disease had 76 percent greater odds of being non-adherent with their medications compared to patients who were not depressed. The findings were published online by the Journal of General Internal Medicine.
The study is the largest systematic review to date to look at the role that depression plays in medication adherence among patients in the United States.
"These findings provide the best evidence to date that depression is an important risk factor that may influence whether patients adhere to their medications," said Dr. Walid F. Gellad, the study's senior author and a natural scientist at RAND, a nonprofit research organization. "There are important implications for both patient health and for health care costs.
"Doctors and other providers should periodically ask patients with depression about medication adherence. Also, when treating a patient who is not taking their medication correctly, they should consider the possibility that depression is contributing to the problem."
Poor adherence to prescribed medication is a well-known problem that is associated with higher death rates among people with chronic illnesses. It is also blamed for increasing U.S. health care costs.
Researchers from RAND and the Claremont Graduate School conducted the study by examining past studies that have measured medication adherence. They combined information from 31 studies involving more than 18,000 people -- significantly more than past reviews –to examine the link between medication adherence and depression.
The study is the first to review the association between depression and medication adherence for patients with high blood pressure and high cholesterol. Other conditions examined in the study include coronary heart disease, diabetes and asthma. The link between depression and medication adherence did not vary significantly between the different chronic illnesses, said Gellad, who is also a physician with the VA Pittsburgh Healthcare System.
"The consistent link between depression and nonadherence across all these illnesses underscores the seriousness of the role that depression plays in keeping people from properly managing chronic conditions," said Jerry L. Grenard, the study's lead author and an assistant professor at the Claremont Graduate School. "That consistency also suggests that lessons learned about how to improve medication adherence among depressed patients with one disease may be applied to other chronic conditions."
Researchers say that depression is just one barrier to getting patients to follow medication recommendations. Additional well-documented barriers to medication adherence are dose complexity and patient cost-sharing. Other barriers that may play a role include beliefs about medications, social support, side effects and provider factors.
###
The study was supported by the Agency for Healthcare Research and Quality and by Mehlman Vogel Castagnetti.
Other authors of the study are Brett A. Munjas, John L. Adams, Marika Suttorp and Margaret Maglione of RAND, and Elizabeth A. McGlynn of Kaiser Permanente.
RAND Health, a division of the RAND Corporation, is the nation's largest independent health policy research program, with a broad research portfolio that focuses on health care costs, quality and public health preparedness, among other topics.
Depression associated with poor medication adherence in patients with chronic illnesses
2011-05-11
ELSE PRESS RELEASES FROM THIS DATE:
Study: Lowering cost doesn't increase hearing aid purchases
2011-05-11
DETROIT – Lowering the cost of hearing aids isn't enough to motivate adults with mild hearing loss to purchase a device at a younger age or before their hearing worsens, according to researchers at Henry Ford Hospital.
A new study shows that simply lowering the cost of hearing aids – even by as much as 40% – does not improve hearing aid purchase for patients with partial insurance coverage or those who need to cover the entire cost out of pocket.
Only patients with full insurance coverage for hearing aids get them at a younger age and with significantly less hearing ...
Zebrafish models identify high-risk genetic features in leukemia patients
2011-05-11
SALT LAKE CITY—Leukemia is the most common childhood cancer; it also occurs in adults. Now researchers working with zebrafish at Huntsman Cancer Institute (HCI) at the University of Utah have identified previously undiscovered high-risk genetic features in T-cell acute lymphocytic leukemia (T-ALL), according to an article published online May 9, 2011, in the cancer research journal Oncogene. When compared to samples from human patients with T-ALL, these genetic characteristics allowed scientists to predict which patients may have more aggressive forms of the disease that ...
2 new studies describe likely beneficiaries of health care reform in California
2011-05-11
According to two new policy briefs from the UCLA Center for Health Policy Research, the majority of state residents likely to be eligible for federally mandated health insurance coverage initiatives in California in 2014 are also those who may be least likely to excessively use costly health services: men, singles and those of working age.
As a result of last year's passage of the federal Patient Protection and Affordable Care Act (ACA), up to 4.57 million previously uninsured or underinsured Californians may be eligible for coverage, either through an expansion of ...
Less than half of patients with MS continually adhere to drug therapies for treatment: Study
2011-05-11
TORONTO, Ont., May 11, 2011 — Disease-modifying drugs (DMDs) are injected medications used to slow the progression of multiple sclerosis (MS), and have been shown to reduce the frequency and severity of relapses. But according to a new study led by St. Michael's Hospital and the Institute for Clinical Evaluative Sciences (ICES), adherence to all DMDs is low, with less than half of patients, or 44 per cent, continually adherent after two years.
"There are a number of reasons why adherence to therapies of proven value might be low," says Dr. Paul O'Connor, director of the ...
Harnessing the energy of the Sun: New technique improves artificial photosynthesis
2011-05-11
This discovery will make it possible to improve photoelectrochemical cells. In the same way that plants use photosynthesis to transform sunlight into energy, these cells use sunlight to drive chemical reactions that ultimately produce hydrogen from water. The process involves using a light-sensitive semi-conducting material such as cuprous oxide to provide the current needed to fuel the reaction. Although it is not expensive, the oxide is unstable if exposed to light in water. Research by
Adriana Paracchino and Elijah Thimsen, published May 8, 2011 in the journal Nature ...
Foot and mouth disease may spread through shedding skin cells
2011-05-11
LIVERMORE, Calif. --Skin cells shed from livestock infected with foot and mouth disease could very well spread the disease.
In a new paper appearing in the Proceedings of the Royal Society B, Lawrence Livermore National Laboratory scientist Michael Dillon proposed that virus-infected skin cells could be a source of infectious foot and mouth disease virus aerosols. His proposal is based on the facts that foot and mouth disease virus is found in skin and that airborne skin cells are known to transmit other diseases.
The proposal could lead to new methods for surveillance ...
Doppler effect found even at molecular level – 169 years after its discovery
2011-05-11
CORVALLIS, Ore. – Whether they know it or not, anyone who's ever gotten a speeding ticket after zooming by a radar gun has experienced the Doppler effect – a measurable shift in the frequency of radiation based on the motion of an object, which in this case is your car doing 45 miles an hour in a 30-mph zone.
But for the first time, scientists have experimentally shown a different version of the Doppler effect at a much, much smaller level – the rotation of an individual molecule. Prior to this such an effect had been theorized, but it took a complex experiment with a ...
Tiny talk on a barnacle's back
2011-05-11
Even the merest of microbes must be able to talk, to be able to interact with its environment and with others to not just survive, but to thrive. This cellular chatter comes in the form of signaling molecules and exchanged metabolites (molecules involved in the process of metabolism or living) that can have effects far larger than the organism itself. Humans, for example, rely upon thousands of products derived from microbially produced molecules, everything from antibiotics and food supplements to ingredients used in toothpaste and paint.
Remarkably, most of what's known ...
Win-Win Deal From Halfpricesoft.com Opens Check Writing Software For More Businesses
2011-05-11
Halfpricesoft.com (http://www.halfpricesoft.com) announces that ezCheckPrinting users can get the popular check writing software or blank check stock for free when they check out through TrialPay offer from halfpricesoft.com site.
"It's a win-win-win-win situation: the customer gets free product, we make sales, the TrialPay advertiser makes sales, and TrialPay gets commissions," said Dr Ge, the founder of halfpricesoft.com. "In a down economy, companies need to streamline and increase efficiency, so they can be more productive with every minute and every ...
Study suggests systemic sclerosis is an independent risk factor for atherosclerosis
2011-05-11
A new study by researchers in Hong Kong suggests that systemic sclerosis is an independent determinant for moderate to severe coronary calcification or atherosclerosis. Conventional cardiovascular risk factors such as age and hypertension predispose patients with systemic sclerosis to plaque build-up in the heart arteries similar to the general population. Details of this study are now available in Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology (ACR).
Systemic sclerosis, also known as scleroderma, is a ...